Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Guilherme Dabus

Neuroradiology Miami, FL Medical Doctor

NPI 1386602399 CMS profile 17402

8950 N Kendall Dr Ste 407W, Miami, FL 33176

Open in the dashboard

General payments

$437,934

347 records reported · program years 2019–2025

Research payments

$7,200

Paid to them · 11 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$30,400 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Guilherme Dabus of Miami, FL is reported in the CMS Open Payments database as having received $437,934 across 347 general payments and $7,200 in research payments paid to them. Separately, studies naming them as principal investigator received $30,400 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $101,261 71
2024 General $15,457 20
2023 General $54,843 46
2022 General $72,332 54
2021 General $31,536 31
2020 General $78,762 31
2020 Research $5,700 8
2019 General $83,743 94
2019 Research $1,500 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Guilherme Dabus
  • Neuroradiology median
  • Middle half of Neuroradiology
  • National median

In program year 2025, general payments to Guilherme Dabus were reported at $101,261. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.

Show as a table
Year Guilherme Dabus Neuroradiology median Middle half National median
2019 $83,743 $288 $71–$2,035 $163
2020 $78,762 $165 $32–$1,794 $114
2021 $31,536 $238 $42–$1,807 $132
2022 $72,332 $191 $49–$1,388 $149
2023 $54,843 $228 $56–$1,148 $160
2024 $15,457 $241 $97–$2,192 $164
2025 $101,261 $279 $65–$2,205 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. MicroVention, Inc. $108,685 96 payments
  2. Penumbra, Inc. $77,735 64 payments
  3. Medtronic, Inc. $73,266 11 payments
  4. Medtronic USA, Inc. $64,537 25 payments
  5. Stryker Corporation $45,809 54 payments
  6. Route 92 Medical, Inc. $21,358 10 payments
  7. Perfuze Limited $11,749 2 payments
  8. Medical Device Business Services, Inc. $11,511 8 payments
  9. Rapid Medical LTD $9,219 4 payments
  10. DePuy Synthes Products, Inc. $9,035 4 payments
  11. Other $5,031 69 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $117,810 40 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $104,800 30 payments
  3. Acquisitions $71,509 6 payments
  4. Travel and Lodging $69,215 105 payments
  5. Royalty or License $41,267 1 payment
  6. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $23,200 4 payments
  7. Food and Beverage $8,650 159 payments
  8. Education $1,153 1 payment
  9. Entertainment $330 1 payment
Products named General payments · program years 2019–2025
  1. RIST $57,350 5 payments
  2. Penumbra System Neurointervention $48,009 30 payments
  3. Rist-5F Catheters $41,267 1 payment
  4. Penumbra System Neurointervention $32,122 9 payments
  5. HydroFill Coil $19,475 18 payments
  6. SURPASS EVOLVE $19,300 24 payments
  7. Pipeline $16,628 17 payments
  8. Rist-5F Catheters $14,159 1 payment
  9. FRED $13,943 8 payments
  10. HydroFrame Coil $13,642 14 payments
  11. Other $128,531 241 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $7,200 11 payments

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$116,749

Medicare's payments for the services billed

Medicare patients

138

Average age 76

Services billed

589

91 women, 47 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 44%
Ischemic heart disease 43%
Chronic kidney disease 34%
Depression 33%
Atrial fibrillation 28%
Osteoporosis 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

358 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neuroradiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record